Clinical Trial Update: Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy

View source ↗

Summary

This Clinical Trial Update reports on screening adult AML patients for IDH1 and IDH2 mutations to identify candidates for targeted therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Acute Myeloid Leukemia | Status: UNKNOWN